Insights From the informCLL Registry: Real-World Application of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

被引：0
|
作者：
Ghosh, Nilanjan [1 ]
Brander, Danielle [2 ]
Mato, Anthony R. [3 ]
Sharman, Jeff P. [4 ]
Gutierrez, Meghan [5 ]
Naganuma, Maoko [6 ]
Upasani, Sandhya [6 ]
Alagappan, Divi [7 ]
Huang, Qing [7 ]
Young, Alex [6 ]
Barrientos, Jacqueline C. [8 ]
机构：
[1] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
[2] Duke Univ Hlth Syst, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Willamette Valley Canc Inst & Res Ctr, US Oncol Res, Eugene, OR USA
[5] Lymphoma Res Fdn, New York, NY USA
[6] Pharmacyclics LLC, Sunnyvale, CA USA
[7] Janssen Sci Affairs LLC, Horsham, PA USA
[8] Donald Barbara Zucker Sch Med Hofstra Northwell, Div Med Oncol & Hematol, Northwell Hlth Canc Inst, Lake Success, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
CLL; CLL/SLL; real-world; registry; del(17p); TP53;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-074
引用
收藏
页码：S317 / S317
页数：1
相关论文
共 50 条
  • [1] NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019
    Wierda, William G.
    Byrd, John C.
    Abramson, Jeremy S.
    Bilgrami, Syed F.
    Bociek, Greg
    Brander, Danielle
    Brown, Jennifer
    Chanan-Khan, Asher A.
    Chavez, Julio C.
    Coutre, Steve E.
    Davis, Randall S.
    Fletcher, Christopher D.
    Hill, Brian
    Kahl, Brad S.
    Kamdar, Manali
    Kaplan, Lawrence D.
    Khan, Nadia
    Kipps, Thomas J.
    Ma, Shuo
    Malek, Sami
    Mato, Anthony
    Mosse, Claudio
    Neppalli, Vishala T.
    Shadman, Mazyar
    Siddiqi, Tanya
    Stephens, Deborah
    Wagner, Nina
    Dwyer, Mary A.
    Sundar, Hema
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (01): : 12 - 20
  • [2] NCCN Guidelines Update: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Stephens, Deborah M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 563 - 566
  • [3] NCCN Guidelines® Insights Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017 Featured Updates to the NCCN Guidelines
    Wierda, William G.
    Zelenetz, Andrew D.
    Gordon, Leo I.
    Abramson, Jeremy S.
    Advani, Ranjana H.
    Andreadis, C. Babis
    Bartlett, Nancy
    Byrd, John C.
    Caimi, Paolo
    Fayad, Luis E.
    Fisher, Richard I.
    Glenn, Martha J.
    Habermann, Thomas M.
    Harris, Nancy Lee
    Hernandez-Ilizaliturri, Francisco
    Hoppe, Richard T.
    Horwitz, Steven M.
    Kaminski, Mark S.
    Kelsey, Christopher R.
    Kim, Youn H.
    Krivacic, Susan
    LaCasce, Ann S.
    Martin, Michael G.
    Nademanee, Auayporn
    Porcu, Pierluigi
    Press, Oliver
    Rabinovitch, Rachel
    Reddy, Nishitha
    Reid, Erin
    Roberts, Kenneth
    Saad, Ayman A.
    Snyder, Erin D.
    Sokol, Lubomir
    Swinnen, Lode J.
    Vose, Julie M.
    Yahalom, Joachim
    Dwyer, Mary A.
    Sundar, Hema
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (03): : 293 - 311
  • [4] Real-world outcomes by race in patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Final analysis results from the informCLL registry.
    Barrientos, Jacqueline Claudia
    Sharman, Jeff Porter
    Gutierrez, Meghan E.
    Wu, Linda
    Qureshi, Zaina P.
    Raz, Anat
    Girardi, Vincent
    Naganuma, Maoko
    Ghosh, Nilanjan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 Featured Updates to the NCCN Guidelines
    Wierda, William G.
    Brown, Jennifer
    Abramson, Jeremy S.
    Awan, Farrukh
    Bilgrami, Syed F.
    Bociek, Greg
    Brander, Danielle
    Chanan-Khan, Asher A.
    Coutre, Steve E.
    Davis, Randall S.
    Eradat, Herbert
    Fletcher, Christopher D.
    Gaballa, Sameh
    Ghobadi, Armin
    Hamid, Muhammad Saad
    Hernandez-Ilizaliturri, Francisco
    Hill, Brian
    Kaesberg, Paul
    Kamdar, Manali
    Kaplan, Lawrence D.
    Khan, Nadia
    Kipps, Thomas J.
    Ma, Shuo
    Mato, Anthony
    Mosse, Claudio
    Schuster, Stephen
    Siddiqi, Tanya
    Stephens, Deborah M.
    Ujjani, Chaitra
    Wagner-Johnston, Nina
    Woyach, Jennifer A.
    Ye, J. Christine
    Dwyer, Mary A.
    Sundar, Hema
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (06): : 622 - 634
  • [6] NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 (vol 20, pg 622, 2022)
    Wierda, William G.
    Brown, Jennifer
    Abramson, Jeremy S.
    Awan, Farrukh
    Bilgrami, Syed F.
    Bociek, Greg
    Brander, Danielle
    Chanan-Khan, Asher A.
    Coutre, Steve E.
    Davis, Randall S.
    Eradat, Herbert
    Fletcher, Christopher D.
    Gaballa, Sameh
    Ghobadi, Armin
    Muhammad, Saad Hamid
    Hernandez-Ilizaliturri, Francisco
    Hill, Brian
    Kaesberg, Paul
    Kamdar, Manali
    Kaplan, Lawrence D.
    Khan, Nadia
    Kipps, Thomas J.
    Ma, Shuo
    Mato, Anthony
    Mosse, Claudio
    Schuster, Stephen
    Siddiqi, Tanya
    Stephens, Deborah M.
    Ujjani, Chaitra
    Wagner-Johnston, Nina
    Woyach, Jennifer A.
    Ye, J. Christine
    Dwyer, Mary A.
    Sundar, Hema
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (07): : XXIV - XXIV
  • [7] Real-World Prognostic Biomarker Testing, Treatment Patterns and Dosing Among 1461 Patients (pts) with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) from the informCLL Prospective Observational Registry
    Mato, Anthony R.
    Barrientos, Jacqueline C.
    Sharman, Jeff P.
    Brander, Danielle M.
    Gutierrez, Meghan
    Kadish, Karen
    Arango-Hisijara, Israel
    Upasani, Sandhya
    Han, Jennifer
    Huang, Qing
    Iyengar, Reethi
    Ghosh, Nilanjan
    BLOOD, 2020, 136
  • [8] Real-world treatment patterns and outcomes of zanubrutinib in chronic lymphocytic leukemia and small lymphocytic leukemia (CLL/SLL)
    Krackeler, Margaret
    Chee, Bryant
    Orchanian, Arthur K.
    Law, Lisa Y.
    Lopez, Alfredo R.
    Buchanan, Susan
    Maglinte, Gregory A.
    Liu, Raymond
    Zhu, Zheng
    Sakoda, Lori C.
    Tavakoli, Jahan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Real-World Outcomes with First-Line Ibrutinib (Ibr) Versus Chemoimmunotherapy (CIT) in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Final Analysis Results from the InformCLL Registry
    Ghosh, Nilanjan
    Sharman, Jeff P.
    Barrientos, Jacqueline C.
    Brander, Danielle
    Gutierrez, Meghan
    Wu, Linda
    Qureshi, Zaina P.
    Upasani, Sandhya
    Naganuma, Maoko
    Mato, Anthony R.
    BLOOD, 2022, 140 : 7047 - 7049
  • [10] Real-world risk of bleeding events in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) treated with BTKi
    Moslehi, Javid J.
    Wahlstrom, Svea K.
    Teschemaker, Anna
    Mackey, Rachel H.
    DeVincenzo, Diana
    Carabuena, Leslie A.
    Thompson, Samantha L.
    Gordon, Brittaney
    Rosenthal, Ning A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345